Complete ablation of esophageal epithelium with a balloon-based bipolar electrode: a phased evaluation in the porcine and in the human esophagus.

BACKGROUND The aim of this study was to evaluate the endoscopic and the histologic effects of a balloon-based bipolar radiofrequency electrode for ablation of porcine and human esophageal epithelium. METHODS All procedures were performed with a balloon-based, bipolar radiofrequency system that creates a circumferential, thin-layer epithelial ablation zone within the esophagus. In Phase I, multiple ablations were created in 10 farm swine, followed by acute euthanasia and histologic assessment for completeness of epithelial removal and ablation depth. In Phase II, multiple ablations were created in 19 farm swine, with varying power and energy density, followed by endoscopy at 2 and 4 weeks to assess stricture formation. In Phase III, 3 ablations were created in 12 farm swine, with varying energy density (5, 8, 10, 12, 15, or 20 J/cm 2 ) at 350 W. Animals were euthanized at 48 hours. Histologic examination determined the percentage of epithelium removed and the ablation depth. In Phase IV, 3 patients underwent esophageal epithelial ablation before esophagectomy, creating separate lesions proximal to the tumor. Completeness of epithelial ablation and ablation depth was quantified histologically. RESULTS In Phase I, complete removal of esophageal epithelium was achieved at energy density settings of 9.7 to 29.5 J/cm 2 . In Phase II, 9.7 and 10.6 J/cm 2 produced no stricture, whereas more than 20 J/cm 2 produced a stricture in every case. In Phase III, 8-20 J/cm 2 resulted in 100% epithelial ablation. Five and 8 J/cm 2 spared the muscularis mucosae, whereas 10 J/cm 2 caused injury to the muscularis mucosae but preserved the submucosa. In Phase IV, histologic examination demonstrated full-thickness epithelial removal in areas of electrode contact. Ablation extended only to the muscularis mucosae, without injury to submucosa. CONCLUSIONS In the porcine and the human esophagus, circumferential, full-thickness ablation of epithelium without direct injury to the submucosa is possible and was well tolerated. In all cases, depth of ablation was linearly related to energy density of treatment.

[1]  D. Faigel,et al.  Effective and safe endoscopic reversal of nondysplastic Barrett's esophagus with thermal electrocoagulation combined with high-dose acid inhibition: a multicenter study. , 2001, Gastrointestinal endoscopy.

[2]  B. Overholt,et al.  Photodynamic therapy for Barrett's esophagus: follow-up in 100 patients. , 1999, Gastrointestinal endoscopy.

[3]  N. Talley,et al.  Regression of Barrett's esophagus: the role of acid suppression, surgery, and ablative methods. , 1999, Gastrointestinal endoscopy.

[4]  G. Eisen Ablation therapy for Barrett's esophagus. , 2003, Gastrointestinal endoscopy.

[5]  D. Katzka,et al.  Barrett's esophagus: continuing questions and controversy. , 1999, Gastrointestinal endoscopy.

[6]  B. Reid,et al.  Barrett's esophagus and esophageal adenocarcinoma. , 1991, Gastroenterology clinics of North America.

[7]  C J Stoddard,et al.  Ablation treatment for Barrett oesophagus: what depth of tissue destruction is needed? , 1999, Journal of clinical pathology.

[8]  E. G. Hahn,et al.  KTP laser destruction of dysplasia and early cancer in columnar-lined Barrett's esophagus. , 1999, Gastrointestinal endoscopy.

[9]  Barrett's esophagus and adenocarcinoma. , 1987, Annual review of medicine.

[10]  F. Ramirez,et al.  The efficacy and safety of argon plasma coagulation therapy in Barrett's esophagus. , 1999, Gastrointestinal endoscopy.

[11]  S. Spechler,et al.  Clinical practice. Barrett's Esophagus. , 2002, The New England journal of medicine.

[12]  A. Holt,et al.  Palliation of patients with malignant gastroduodenal obstruction with self-expanding metallic stents: the treatment of choice? , 2004, Gastrointestinal endoscopy.